Pfizer lost its patent on the cholesterol-lowering drug Lipitor on November 30 -- which ... The patent’s expiration means that cheaper, generic versions will soon hit pharmacy shelves.

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

While the introduction of generic alternatives into the market may pose a relief for consumer pockets, the expiration of patents for Lipitor and other drugs in the next three years may result in a ...

and WeRx—to price a month's supply of the cholesterol-lowering drug Lipitor (40 milligrams) and its generic equivalent, atorvastatin, using a ZIP code near our offices in Yonkers, N.Y. Prices ...

Most statin drugs are FDA-approved for children and teens under age 18, but only if they have a genetic condition that cause extremely high levels of LDL (bad) cholesterol. Yet in 2009 ...